New JerseyNew Jersey would require Medicaid payers to use its drug list
New Jersey's Medicaid agency would create a list marking some drugs and other products as preferred, and Medicaid plans and other payers would use it.
What it does
If enacted, Medicaid payers would use a state list of preferred drugs and other products under contracts made, renewed, or changed on or after its start date. Nonpreferred products would face extra criteria.
Argument forChoosing preferred products by how well they work and what they cost could help Medicaid payers control drug spending.
Argument againstExtra criteria for nonpreferred products could delay access for some Medicaid patients who need those treatments.
More detail
The state Medicaid agency would make and maintain a preferred drug list that Medicaid plans and other payers must use. The list would cover drugs and other products for New Jersey Medicaid plans and other Medicaid payers. The agency would weigh how well products work and what they cost when choosing which ones to prefer. Nonpreferred products would have to meet extra list criteria. Products in either group may face use rules, including advance approval. If enacted, the law would start on the first day of the seventh month after enactment and apply to contracts and agreements made, renewed, or changed on or after that day.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Oct 8Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens CommitteeIntroduced
Healthcare